Abilify injection 400 mg

Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection. Each vial contains 400 mg aripiprazole. Abilify Maintena 300 mg

Aripiprazole for prolonged release injectable suspension (Abilify Maintena), 300 mg or 400 mg, IM injection in the treatment of schizophrenia.

suspension for injection to deliver 400 mg or 300 mg of aripiprazole per vial strength. received at least 13 injections Abilify Maintena 400 mg/300 mg

Product Name Abilify, Maintena, Aripiprazole 400 Mg, For Injection - 1 Vial Scientific Name Aripiprazole 400 Mg Vial Category Of Abilify Vial Antipsychotic

After the injection start, the recommended maintenance dose of Abilify Maintena is 400 mg. Abilify Maintena 400 mg should be administered once monthly as a single injection (no sooner than 26 days after the previous injection). If there are adverse reactions with the 400 mg dose, reduction of the dose to 300 mg once monthly should be considered.

ABILIFY MAINTENA (aripiprazole) 400 mg extended-release injectable ABILIFY MAINTENA is a prescription medicine given by injection by a healthcare

Product Name Abilify, Maintena, Aripiprazole 400 Mg, For Injection - 1 Vial Scientific Name Aripiprazole 400 Mg Vial Category Of Abilify Vial Antipsychotic

There is no generic available for this medication. Abilify Maintena Intramuscular injection is available in the strength of 300 mg and 400 mg injections. Side

The approved indication covers the 300 mg and 400 mg vials (for injection) and the 300 mg and 400 mg dual-chamber syringes. ABILIFY MAINTENA